BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Special

South Korea’s Celltrion Buys Eli Lilly’s Branchburg Plant in $330M Deal

Celltrion Group announced that its US subsidiary, Celltrion USA, has entered into a definitive agreement to acquire Eli Lilly’s biologics manufacturi...

September 25, 2025 | News

Single-Use Systems Are Rewiring Biopharma Manufacturing

Bioprocess, Unbottled Single-use systems (SUS) have become a transformative force in biopharmaceutical processing, offering an alternative to trad...

September 16, 2025 | Report

The State of Biotech and Life Science Jobs in Asia Pacific – 2025

In 2025, Asia-Pacific has emerged as the fastest-growing hub for biotech and life sciences employment, fuelled by a powerful combination of government supp...

September 09, 2025 | Report

Epigenic Therapeutics Raises $60 Million in Series B Financing to Advance Epigenetic Medicine Pipeline

Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series ...

September 09, 2025 | News

Thermo Fisher Expands Strategic Partnership with Sanofi through Acquisition of Ridgefield Sterile Manufacturing Site

Expanded Strategic Partnership Enables Additional U.S. Manufacturing Capacity to Serve Increased Demand for Pharma/Biotech Customers Thermo Fisher Scienti...

September 03, 2025 | News

Transforming Cancer Care in Japan and Asia-Pacific: Thermo Fisher’s Jane Li on Accelerating Precision Oncology with Next-Gen Diagnostics

BioPharma APAC spoke with Jane Li, Senior Director, Pharma CDx and CRO Partnership at Thermo Fisher Scientific, about the development of the Oncomine&trade...

August 25, 2025 | Expert Insight

Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape

Invisible chemical impurities in medicines can pose very visible risks to patient safety and pharmaceutical reputations. In recent years, a quiet c...

August 19, 2025 | Analysis

“Spatial Biology at Scale: 10x Genomics CEO Serge Saxonov on Redefining Precision Medicine with TISHUMAP”

The future of medicine is being shaped at the intersection of spatial biology and artificial intelligence—and 10x Genomics is l...

August 07, 2025 | Interaction

Bridging Real-World Evidence and AI: Unlocking Smarter, Faster Clinical Research in Asia

Having worked with pharma clients, healthcare providers, and digital platforms across the Asia-Pacific region, I’ve seen the challenges first-hand&md...

August 04, 2025 | Opinion

Precision Therapies Set to Unlock USD 1.6 Trillion in Economic Impact Across Asia-Pacific

As Asia-Pacific bears nearly half of the global cancer burden, precision medicine is emerging not only as a clinical breakthrough but also as a powerful ec...

August 04, 2025 | Interview

Fighting Dengue in a Changing Climate: Takeda’s Vision for Resilient Health Systems in Emerging Markets

Dengue is no longer a seasonal threat. It is a growing climate-driven crisis. With rising global temperatures, shifting rainfall patterns and rapid urbanis...

August 04, 2025 | Expert Insight

Nebius Is Accelerating Drug Discovery with AI Infrastructure That Slashes Timelines from Years to Months

The traditional 7–10-year timeline for drug discovery is rapidly becoming obsolete. Thanks to advances in AI and compute infrastructure, pioneers lik...

August 04, 2025 | Interview

Johor’s Healthcare Transformation: Billions Poured into Malaysia’s Life Sciences Engine (2022–2025)

Johor’s Healthcare & Life Sciences Investment Boom (2022–2025) Over the past three years, the southern Malaysian state of Johor has emerge...

July 30, 2025 | Report

How Innovation Gaps in Biopharma Raise New Safety Concerns

The biopharmaceutical industry stands at the forefront of medical innovation and delivers remarkable advances in disease treatment and prevention. Breakthr...

July 24, 2025 | News

Stay Connected